The median overall survival time for oxaliplatin, irinotecan and cetuximab treatment in advanced gastric cancer is survival was 38.1 weeks.

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.